Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by SeaOfSandon Nov 07, 2019 8:14am
86 Views
Post# 30319981

RE:News

RE:NewsImagine the stock is being controlled otherwise and held into its ZigZag Bollinger Band pattern until .. they are happy. From top on 10/11 C$0.12 to the bottom today. Should be back to C$0.11-0.12 (bb top - 200dma) - then events will tell us: Breakout or not.

I completed my DD update (some copied here, all on ceo.ca) and it looks all quite legit.
Even Oncore Pharma with its relationship to BodyCheck (Netherlands, Luxemburg and Belgium) and the latter has a relationship with HartKliniek (NL). Not the immediate cash shower, but it does look legit and may give a min EBITDA $6M (USD) per year baseline.

Then see the insider activity, also quite promising.


And yes, it is the older trick in the world to sell down news and then buying it back up :)
Bullboard Posts